UNQUOTE

DENMARK- 7TM AS secures fourth-round investments of $22m

  • Linn
  • LinkedIn  
  • Google plus  

7TM Pharma AS, a Danish pharmaceutical, has raised around $22 million in a fourth-round funding from SR One Ltd, one of GlaxoSmithKline’s independent corporate healthcare venture capital fund. Other investors that have participated are Alta Partners, Baker/Tisch Investments, Dansk Innovationsinvestering, Index Ventures, Johnson & Johnson Development Corp., LD Pensions, Lombard Odier Darier Hentsch, Novo AS and Scottish Widows Investment Partnership.

7TM Pharma was founded in 2000 as a spinout from the University of Copenhagen by internationally recognised pioneers in 7TM receptor research. The company has about 50 employees, based in Copenhagen.
  • LinkedIn  
  • Google plus  

More on Expansion

Latest News